$EXPI
EXP World Holdings, Inc.

2022 Q1 Form 10-Q Financial Statement

#000155837022006930 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $1.011B $1.077B $583.8M
YoY Change 73.12% 76.75% 115.1%
Cost Of Revenue $927.3M $993.9M $530.3M
YoY Change 74.86% 77.83% 117.87%
Gross Profit $83.46M $83.09M $53.50M
YoY Change 56.01% 64.85% 91.07%
Gross Profit Margin 8.26% 7.71% 9.16%
Selling, General & Admin $79.02M $81.54M $48.56M
YoY Change 62.74% 91.41% 74.64%
% of Gross Profit 94.68% 98.14% 90.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.616M $1.737M $1.007M
YoY Change 60.48% 44.75% 33.03%
% of Gross Profit 1.94% 2.09% 1.88%
Operating Expenses $1.006B $81.54M $578.9M
YoY Change 73.83% 91.41% 113.45%
Operating Profit $4.442M $1.543M $4.929M
YoY Change -9.88% -80.22% 2236.02%
Interest Expense -$317.0K -$183.0K $0.00
YoY Change
% of Operating Profit -7.14% -11.86% 0.0%
Other Income/Expense, Net -$727.0K -$133.0K $128.0K
YoY Change -667.97% -316.95%
Pretax Income $3.715M $1.227M $5.057M
YoY Change -26.54% -84.27% 3226.97%
Income Tax -$5.150M -$14.23M $210.0K
% Of Pretax Income -138.63% -1159.66% 4.15%
Net Earnings $8.882M $15.50M $4.846M
YoY Change 83.29% 101.44% 2836.97%
Net Earnings / Revenue 0.88% 1.44% 0.83%
Basic Earnings Per Share $0.06 $0.03
Diluted Earnings Per Share $0.06 $98.49K $0.03
COMMON SHARES
Basic Shares Outstanding 149.2M 148.8M 144.4M
Diluted Shares Outstanding 156.8M 158.7M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $130.1M $108.2M $104.4M
YoY Change 24.61% 8.13% 135.67%
Cash & Equivalents $130.1M $108.2M $104.4M
Short-Term Investments
Other Short-Term Assets $126.3M $481.0K $73.90M
YoY Change 70.89% -80.12% 435.51%
Inventory
Prepaid Expenses $5.834M
Receivables $143.0M $133.5M $88.48M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $399.3M $319.3M $266.8M
YoY Change 49.7% 50.46% 187.77%
LONG-TERM ASSETS
Property, Plant & Equipment $19.02M $15.90M $9.042M
YoY Change 110.4% 102.62% 29.17%
Goodwill $12.95M $12.95M $12.95M
YoY Change 0.0% 0.0%
Intangibles $7.204M $7.528M $8.121M
YoY Change -11.29% -9.84%
Long-Term Investments
YoY Change
Other Assets $61.24M $55.65M
YoY Change
Total Long-Term Assets $102.8M $94.51M $30.84M
YoY Change 233.34% 215.44% 71.33%
TOTAL ASSETS
Total Short-Term Assets $399.3M $319.3M $266.8M
Total Long-Term Assets $102.8M $94.51M $30.84M
Total Assets $502.1M $413.8M $297.6M
YoY Change 68.73% 70.87% 168.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.191M $7.158M $5.119M
YoY Change 40.48% 80.89% 31.26%
Accrued Expenses $128.7M $111.7M $79.39M
YoY Change 62.16% 77.96% 110.59%
Deferred Revenue $116.9M $67.67M $66.11M
YoY Change 76.9% 143.59%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $916.0K
YoY Change -100.0% -8.4%
Total Short-Term Liabilities $253.1M $186.8M $151.9M
YoY Change 66.64% 93.29% 189.87%
LONG-TERM LIABILITIES
Long-Term Debt $2.714M $2.714M $1.726M
YoY Change 57.24% -5.63% 7.88%
Other Long-Term Liabilities $779.0K $765.0K $400.0K
YoY Change 94.75% 665.0% -42.86%
Total Long-Term Liabilities $2.714M $2.714M $1.726M
YoY Change 57.24% -5.63% -24.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $253.1M $186.8M $151.9M
Total Long-Term Liabilities $2.714M $2.714M $1.726M
Total Liabilities $256.6M $190.3M $154.0M
YoY Change 66.64% 91.06% 180.49%
SHAREHOLDERS EQUITY
Retained Earnings $33.53M $30.51M -$34.32M
YoY Change -197.72% -177.91%
Common Stock $450.6M $401.5M $1.000K
YoY Change 45057100.0% 83.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $7.884M $6.752M $3.035M
Shareholders Equity $244.4M $222.2M $142.6M
YoY Change
Total Liabilities & Shareholders Equity $502.1M $413.8M $297.6M
YoY Change 68.73% 70.87% 168.84%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $8.882M $15.50M $4.846M
YoY Change 83.29% 101.44% 2836.97%
Depreciation, Depletion And Amortization $1.616M $1.737M $1.007M
YoY Change 60.48% 44.75% 33.03%
Cash From Operating Activities $111.5M $48.48M $78.92M
YoY Change 41.29% 58.95% 351.25%
INVESTING ACTIVITIES
Capital Expenditures $4.684M -$4.264M $2.257M
YoY Change 107.53% 103.05% 66.57%
Acquisitions $1.500M
YoY Change
Other Investing Activities $0.00 -$996.0K -$1.500M
YoY Change -100.0% -89.05%
Cash From Investing Activities -$4.684M -$5.260M -$3.757M
YoY Change 24.67% -53.45% 177.27%
FINANCING ACTIVITIES
Cash Dividend Paid $5.859M
YoY Change
Common Stock Issuance & Retirement, Net $29.96M $34.01M
YoY Change -11.92% 230.02%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.74M -34.78M -32.64M
YoY Change 9.52% 544.07% 288.99%
NET CHANGE
Cash From Operating Activities 111.5M 48.48M 78.92M
Cash From Investing Activities -4.684M -5.260M -3.757M
Cash From Financing Activities -35.74M -34.78M -32.64M
Net Change In Cash 71.12M 8.439M 42.57M
YoY Change 67.06% -38.85% 505.25%
FREE CASH FLOW
Cash From Operating Activities $111.5M $48.48M $78.92M
Capital Expenditures $4.684M -$4.264M $2.257M
Free Cash Flow $106.8M $52.74M $76.66M
YoY Change 39.34% 61.79% 375.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001495932
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38493
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
EXP WORLD HOLDINGS, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0681092
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2219 Rimland Drive, Suite 301
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bellingham
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98226
CY2022Q1 dei City Area Code
CityAreaCode
360
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
685-4206
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
EXPI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150416865
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130092000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
116939000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
67673000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2417000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2198000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
142963000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
133489000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9348000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9916000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
399342000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
319315000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19024000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15902000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2387000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2482000
CY2022Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2510000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2827000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7204000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7528000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
58728000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52827000
CY2022Q1 us-gaap Goodwill
Goodwill
12945000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
CY2022Q1 us-gaap Assets
Assets
502140000
CY2021Q4 us-gaap Assets
Assets
413826000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7191000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7158000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
116939000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
67673000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
128741000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
111672000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
238000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
311000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
253109000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
186814000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2714000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2714000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
779000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
765000
CY2022Q1 us-gaap Minority Interest
MinorityInterest
1169000
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1364000
CY2022Q1 us-gaap Liabilities
Liabilities
256602000
CY2021Q4 us-gaap Liabilities
Liabilities
190293000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158300605
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
150416865
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148764592
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
450570000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
401479000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7883740
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6751692
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
239965000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
210009000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33533000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30510000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
229000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
188000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
244369000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
222169000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245538000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
223533000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
502140000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413826000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010731000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
583833000
CY2022Q1 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
927267000
CY2021Q1 expi Commissions And Other Agent Related Costs
CommissionsAndOtherAgentRelatedCosts
530347000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
75322000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46300000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3700000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2257000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1006289000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
578904000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4442000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4929000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-410000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
134000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-317000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-727000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
128000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3715000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5057000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5149000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
211000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8864000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4846000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
8882000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4846000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149226166
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144354991
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156842721
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158722126
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8864000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4846000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
8882000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4846000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
41000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
47000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8923000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4893000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
41000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
47000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245538000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
143613000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8864000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
4846000
CY2022Q1 us-gaap Depreciation
Depreciation
1616000
CY2021Q1 us-gaap Depreciation
Depreciation
1007000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
342000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303000
CY2022Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
361000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
219000
CY2021Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
385000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-317000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000
CY2022Q1 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
7798000
CY2021Q1 expi Share Based Compensation Agent Growth Incentive Programs
ShareBasedCompensationAgentGrowthIncentivePrograms
5472000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3511000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3109000
CY2022Q1 expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
38500000
CY2021Q1 expi Share Based Compensation Agent Equity Program
ShareBasedCompensationAgentEquityProgram
21402000
CY2022Q1 expi Deferred Tax Asset Change
DeferredTaxAssetChange
-5901000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9846000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11907000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-496000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
459000
CY2022Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-49266000
CY2021Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-38324000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
74000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1161000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15854000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
15420000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-150000
CY2022Q1 expi Proceeds From Payments For Other Operating Activities
ProceedsFromPaymentsForOtherOperatingActivities
36000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111507000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78919000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4684000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2257000
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1500000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4684000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3757000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29956000
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34009000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
498000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1373000
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
426000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5859000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35743000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32636000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71121000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42573000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247031000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170497000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
483000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3000
CY2022Q1 expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
246000
CY2021Q1 expi Property Plant And Equipment Purchases In Accounts Payable
PropertyPlantAndEquipmentPurchasesInAccountsPayable
141000
CY2021Q1 expi Cash And Cash Equivalent At Carrying Value Net Activity
CashAndCashEquivalentAtCarryingValueNetActivity
4249000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimate</span>s</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to allowance for credit losses, legal contingencies, income taxes, revenue recognition, stock-based compensation, </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">goodwill, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 6pt 0pt;">When necessary, the Company will reclassify certain amounts in prior-period financial statements to conform to the current period’s presentation. No reclassifications occurred during the current period.</p>
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100143000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
27781000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127924000
CY2021Q1 expi Restricted Cash And Cash Equivalents Net Activity
RestrictedCashAndCashEquivalentsNetActivity
38324000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42573000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104392000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
66105000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170497000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108237000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
67673000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175910000
CY2022Q1 expi Cash And Cash Equivalent At Carrying Value Net Activity
CashAndCashEquivalentAtCarryingValueNetActivity
21855000
CY2022Q1 expi Restricted Cash And Cash Equivalents Net Activity
RestrictedCashAndCashEquivalentsNetActivity
49266000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
71121000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130092000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
116939000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247031000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24545000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20850000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13328000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11711000
CY2022Q1 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
11217000
CY2021Q4 expi Property Plant And Equipment Excluding Assets Under Construction
PropertyPlantAndEquipmentExcludingAssetsUnderConstruction
9139000
CY2022Q1 expi Assets Under Development
AssetsUnderDevelopment
7807000
CY2021Q4 expi Assets Under Development
AssetsUnderDevelopment
6763000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19024000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15902000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1616000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1007000
CY2022Q1 us-gaap Goodwill
Goodwill
12945000
CY2021Q4 us-gaap Goodwill
Goodwill
12945000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9797000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2593000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7204000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9780000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2252000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7528000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
342000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303000
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
96000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
96000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
71000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05048
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
109000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04481
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
201000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
163000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
90000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
90000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
90000
CY2022Q1 expi Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
405000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1039000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
22000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1017000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
155516284
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
146677786
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
723194
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
547776
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158300605
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147934768
CY2020Q4 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
2093000
CY2021Q1 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1221000
CY2021Q1 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
3314000
expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
4341000
CY2022Q1 expi Increase Decrease In Stock Grant Liability
IncreaseDecreaseInStockGrantLiability
1906000
CY2022Q1 expi Stock Grants Reclassified From Liability To Equity
StockGrantsReclassifiedFromLiabilityToEquity
691000
CY2022Q1 expi Stock Compensation Liability Activity
StockCompensationLiabilityActivity
5556000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
26.04
CY2018Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
25000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000.0
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
400000000.0
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6751692
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2534494
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1132048
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500910
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7883740
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3035404
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
8882000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
4846000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149226166
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14367135
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
156842721
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
158722126
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144354991
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7616555
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
392483
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6506
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5150000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
210000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.3797
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0417
CY2022Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
10000000.0
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1

Files In Submission

Name View Source Status
0001558370-22-006930-index-headers.html Edgar Link pending
0001558370-22-006930-index.html Edgar Link pending
0001558370-22-006930.txt Edgar Link pending
0001558370-22-006930-xbrl.zip Edgar Link pending
expi-20220331.xsd Edgar Link pending
expi-20220331x10q.htm Edgar Link pending
expi-20220331x10q001.jpg Edgar Link pending
expi-20220331x10q_htm.xml Edgar Link completed
expi-20220331xex10d1.htm Edgar Link pending
expi-20220331xex10d1001.jpg Edgar Link pending
expi-20220331xex10d2.htm Edgar Link pending
expi-20220331xex31d1.htm Edgar Link pending
expi-20220331xex31d2.htm Edgar Link pending
expi-20220331xex32d1.htm Edgar Link pending
expi-20220331xex32d2.htm Edgar Link pending
expi-20220331_cal.xml Edgar Link unprocessable
expi-20220331_def.xml Edgar Link unprocessable
expi-20220331_lab.xml Edgar Link unprocessable
expi-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending